MedTrace Logo

Evaluation of Four Different Dosing Regimens of Cross-Linked Polyelectrolyte (CLP) in Healthy Volunteers

NCT02079233 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2014-03-05

No results posted yet for this study

Summary

This is a study to determine the effect of four different dosing regimens of CLP in normal healthy volunteers.

Conditions

  • Healthy

Interventions

DRUG

Cross-Linked Polyelectrolyte (CLP)

CLP was administered orally, in capsules, for 7 consecutive days.

Sponsors & Collaborators

  • Sorbent Therapeutics

    lead INDUSTRY

Principal Investigators

  • Shanthini A. Daniel, MD · Jasper Clinic, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2010-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02079233 on ClinicalTrials.gov